Foghorn Therapeutics Inc. - COMMON STOCK (FHTX)

Historical Holders from Q4 2020 to Q3 2025

Symbol
FHTX on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
55,781,559
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
40,899,067
Holdings value
$199,997,332
% of all portfolios
0%
Number of holders
86
Number of buys
41
Number of sells
-31
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Foghorn Therapeutics Inc. - COMMON STOCK (FHTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 10.2% $24,977,866 5,689,719 FMR LLC 31 Dec 2024

Institutional Holders of Foghorn Therapeutics Inc. - COMMON STOCK (FHTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 40,899,067 $199,997,332 -$252,615 $4.89 86
2025 Q2 40,966,679 $192,544,370 +$2,995,463 $4.7 79
2025 Q1 40,422,738 $147,539,082 +$554,807 $3.65 89
2024 Q4 40,250,865 $189,972,345 +$1,515,315 $4.72 86
2024 Q3 39,996,016 $372,365,052 +$3,205,361 $9.31 78
2024 Q2 39,443,565 $226,852,214 +$74,393,685 $5.75 71
2024 Q1 26,459,793 $177,447,258 +$1,618,684 $6.71 67
2023 Q4 26,194,106 $168,954,975 -$3,389,727 $6.45 59
2023 Q3 26,924,936 $134,628,591 +$778,966 $5 61
2023 Q2 26,763,756 $188,422,208 +$3,982,788 $7.04 59
2023 Q1 26,253,067 $162,763,500 +$937,198 $6.2 61
2022 Q4 26,093,883 $166,474,381 -$1,442,468 $6.38 63
2022 Q3 26,307,921 $225,720,907 +$12,954 $8.58 60
2022 Q2 26,276,584 $357,367,427 +$18,367,020 $13.6 55
2022 Q1 24,903,791 $379,088,288 +$4,677,182 $15.23 57
2021 Q4 24,151,188 $552,334,813 +$1,462,679 $22.87 58
2021 Q3 11,606,587 $161,634,440 +$5,200,204 $13.93 44
2021 Q2 11,234,597 $119,870,494 +$2,946,090 $10.67 36
2021 Q1 10,646,057 $139,604,845 -$678,194 $13.18 43
2020 Q4 10,612,558 $212,930,838 +$187,364,837 $20.27 45